Disclosures for "Clinical Characteristics and Treatment Approaches for H3K27-altered Diffuse Midline Glioma in Adolescents and Young Adults"
-
Dr. Lala has nothing to disclose.
-
An immediate family member of Matthias Karajannis has stock in 3M. Matthias Karajannis has stock in Doximity. Matthias Karajannis has stock in Johnson & Johnson. The institution of Matthias Karajannis has received research support from Ymabs. Matthias Karajannis has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Graham has received research support from the Matthew Larson Foundation. The institution of Dr. Graham has received research support from Hyundai Hope on Wheels. The institution of Dr. Graham has received research support from the American Cancer Society. The institution of Dr. Graham has received research support from Team Jack Foundation. The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
-
The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.